Based upon the subgroup Evaluation, we found that there was significant heterogeneity concerning mortality, favorable outcomes, and the whole treatment method powerful rate. Concerning mortality, The rationale for heterogeneity to the subgroup of edaravone dexborneol and EDV was generally attributed to variances in drug dosage. Concerning favorable results, the reason https://franciscotpleo.blogolize.com/examine-this-report-on-buy-neuroprotectives-72373022